These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gemcitabine-induced pseudocellulitis: a case report and review of the literature. Bami H; Goodman C; Boldt G; Vincent M Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665 [TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature. Curtis S; Hong S; Gucalp R; Calvo M Am J Ther; 2016; 23(1):e321-3. PubMed ID: 24451298 [TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the literature. Obeid KM; Venugopal AA Am J Ther; 2013 Jan; 20(1):118-20. PubMed ID: 21768869 [TBL] [Abstract][Full Text] [Related]
13. Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients. Zinzani PL; Magagnoli M; Bendandi M; Orcioni GF; Gherlinzoni F; Albertini P; Pileri SA; Tura S Ann Oncol; 1998 Dec; 9(12):1351-3. PubMed ID: 9932168 [TBL] [Abstract][Full Text] [Related]
14. A case of gemcitabine-related acute lipodermatosclerosis. Nyckowski T; McGregor S; Huang WW J Oncol Pharm Pract; 2019 Jul; 25(5):1271-1274. PubMed ID: 30041585 [TBL] [Abstract][Full Text] [Related]
15. Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer. Li J; Ko CJ; Saif MW Cutan Ocul Toxicol; 2009; 28(3):144-8. PubMed ID: 19527102 [TBL] [Abstract][Full Text] [Related]
16. Widespread Skin Necrosis Secondary to Gemcitabine Therapy. Zito PM; Gonzalez AM; Fox JD; Cronin M; Mackrides N; Kirsner RS; Nichols AJ J Drugs Dermatol; 2018 May; 17(5):582-585. PubMed ID: 29742194 [TBL] [Abstract][Full Text] [Related]